Patient-Tailored, Imaging-Guided, Long-Term Temozolomide Chemotherapy in Patients with Glioblastoma
We present two patients with glioblastoma with an unusually stable clinical course and long-term survival who were treated after surgery and radiotherapy with adjuvant temozolomide (TMZ) chemotherapy for 17 and 20 cycles, respectively. Afterward, adjuvant TMZ chemotherapy was discontinued in one pat...
Main Authors: | Norbert Galldiks, Lutz W. Kracht, Lothar Burghaus, Roland T. Ullrich, Heiko Backes, Anna Brunn, Wolf-Dieter Heiss, Andreas H. Jacobs |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi - SAGE Publishing
2010-01-01
|
Series: | Molecular Imaging |
Online Access: | https://doi.org/10.2310/7290.2010.00002 |
Similar Items
-
Irradiation or temozolomide chemotherapy enhances anti-CD47 treatment of glioblastoma
by: Sharareh Gholamin, et al.
Published: (2020-02-01) -
Aspergillosis in a Patient Receiving Temozolomide for the Treatment of Glioblastoma
by: Rodrigo Ramella Munhoz, et al.
Published: (2013-08-01) -
DGKI methylation status modulates the prognostic value of MGMT in glioblastoma patients treated with combined radio-chemotherapy with temozolomide.
by: Amandine Etcheverry, et al.
Published: (2014-01-01) -
Early assessment of the efficacy of temozolomide chemotherapy in experimental glioblastoma using [18F]FLT-PET imaging.
by: Thomas Viel, et al.
Published: (2013-01-01) -
Quinacrine enhances temozolomide cytotoxicity in temozolomide-sensitive and -resistant glioblastoma cells
by: Pingde Zhang, et al.
Published: (2018-01-01)